SCRIBE THERAPEUTICS
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR. The company’s first technology, called X-Editing (XE) molecules, are highly engineered CRISPR enzymes that provide combined aspects of greater efficacy, specificity, and deliverability than currently available CRISPR genome editing technology. It also a long-term, engineering approach that can help establish CRISPR-based therapies as a new standard of clinical care and expand access to ground... breaking treatments that will impact millions of lives. Scribe Therapeutics is overcoming the limitations of current genome editing technologies by developing custom-engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company built for exceptional specificity within the genome – enabling therapeutic precision and allele-specific targeting. Scribe Therapeutics was founded in 2018 and is headquartered in Alameda, CA, USA.
SCRIBE THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Address:
Alameda, California, United States
Country:
United States
Website Url:
http://www.scribetx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
120 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Nginx Google Apps For Business
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Wellington Management
Wellington Management investment in Series B - Scribe Therapeutics
T. Rowe Price
T. Rowe Price investment in Series B - Scribe Therapeutics
Avoro Ventures
Avoro Ventures investment in Series B - Scribe Therapeutics
Andreessen Horowitz
Andreessen Horowitz investment in Series B - Scribe Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series B - Scribe Therapeutics
OrbiMed
OrbiMed investment in Series B - Scribe Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Scribe Therapeutics
Avoro Capital Advisors
Avoro Capital Advisors investment in Series B - Scribe Therapeutics
Menlo Ventures
Menlo Ventures investment in Series B - Scribe Therapeutics
Andreessen Horowitz
Andreessen Horowitz investment in Series A - Scribe Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-09 | Scribe Therapeutics Appoints David Parrot as Chief Financial Officer and George Manning as Controller |
Official Site Inspections
http://www.scribetx.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Scribe Therapeutics"
Scribe → Careers - scribetx.com
We’re always looking for individuals with drive, creativity, pragmatism, and integrity to join our team.See details»
Scribe Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR. The company’s first technology, called X-Editing (XE) molecules, are highly engineered CRISPR …See details»
Scribe → Platform
Discovery. Naturally occurring CRISPR systems have revolutionized genetic medicine since 2012, when their potential for gene editing was unlocked in the lab of our co-founder, Nobel Laureate …See details»
Scribe Therapeutics Company Overview, Contact Details
[email protected]: [email protected]: 2%. [email protected]: [email protected]: 1%. See more formats. Frequently Asked Questions Where is Scribe Therapeutics 's …See details»
Scribe Therapeutics Company Profile | Management and
Www.scribetx.com . Scribe Therapeutics Profile and History. Scribe Therapeutics is a molecular engineering company focused on creating best-in-class in vivo therapies that permanently …See details»
Scribe Therapeutics - Overview, News & Similar companies
Mar 14, 2024 www.scribetx.com. Revenue $6 Million. Industry Manufacturing General Manufacturing . Most Recent Scoops. Apr 23 2024. Open Position . Mar 15 2024. Open …See details»
Scribe Therapeutics Company Profile 2024: Valuation, …
Scribe Therapeutics General Information Description. Developer of molecular engineering technologies designed to treat genetic diseases. The company's platform offers biological preparations based on engineered cells for medical …See details»
Scribe Therapeutics Appoints David Parrot as Chief Financial …
Mar 9, 2022 To learn more about Scribe’s mission to engineer the future of genetic medicine, visit www.scribetx.com. Contacts Thermal for Scribe Therapeutics Kaustuva Das …See details»
Scribe Therapeutics Expands Collaboration With Biogen to Second …
May 2, 2022 To learn more about Scribe’s mission to engineer the future of genetic medicine, visit www.scribetx.com. Contacts Thermal for Scribe Therapeutics Kaustuva Das …See details»
Scribe Therapeutics Announces Oral Presentation at …
May 2, 2023 To learn more about Scribe’s mission to engineer the future of genetic medicine, visit www.scribetx.com. Contacts. Thermal for Scribe Therapeutics [email protected]. Release Summary.See details»
Scribe → Scribe Therapeutics Expands Collaboration With Biogen …
May 2, 2022 The expanded collaboration further validates Scribe’s position as a leading organization driving the development of novel CRISPR-based therapeutics that treat the …See details»
Scribe Therapeutics Announces Research Collaboration with Sanofi …
Sep 27, 2022 To learn more about Scribe’s mission to engineer the future of genetic medicine, visit www.scribetx.com. Contacts. Thermal for Scribe Therapeutics [email protected]. …See details»
Scribe → Privacy Policy - scribetx.com
Scribe Therapeutics (“us”, “we”, or “our”) operates the scribetx.com website and the new horizon mobile application (the “Service”). This page informs you of our policies regarding the …See details»
Benjamin Oakes Email & Phone Number - ZoomInfo
Benjamin Oakes contact details: Email address: b***@scribetx.com Phone number: (***) ***-**** Who is Benjamin Oakes? Benjamin L. Oakes, PhD, is Co-founder, President, and Chief …See details»
Scribe Therapeutics to Present at the 42nd Annual J.P. Morgan ...
Jan 2, 2024 Media Contact: Thermal for Scribe Therapeutics [email protected] Release Summary Benjamin Oakes, Ph.D., Chief Executive Officer of Scribe, will present at the 42nd …See details»
Scribe-x Mission, Benefits, and Work Culture | Indeed.com
Come see what’s going on inside Scribe-x, including the company culture, employee work-life benefits, and business goals. Discover all the key insights that make people want to work …See details»
More like this - scribetx.com
May 16, 2023See details»
Scribe Therapeutics Presents Data on its X-Editing ... - Business Wire
May 19, 2023 To learn more, visit www.scribetx.com. Contacts. Investor Contact: Stern IR for Scribe Therapeutics [email protected]. Media Contact: Thermal for Scribe Therapeutics …See details»
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR ...
Nov 25, 2024 To learn more, visit www.scribetx.com. | November 25, 2024. Share on Social. share on Twitter or X. share on Linkedin. share onFacebook. share on instagram. More like …See details»